These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene. Martin D; Nguyen Q; Molinolo A; Gutkind JS Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663 [TBL] [Abstract][Full Text] [Related]
3. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma. Montaner S Cell Cycle; 2007 Feb; 6(4):438-43. PubMed ID: 17329974 [TBL] [Abstract][Full Text] [Related]
5. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma. Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770 [TBL] [Abstract][Full Text] [Related]
6. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227 [TBL] [Abstract][Full Text] [Related]
7. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma. Chaisuparat R; Hu J; Jham BC; Knight ZA; Shokat KM; Montaner S Cancer Res; 2008 Oct; 68(20):8361-8. PubMed ID: 18922908 [TBL] [Abstract][Full Text] [Related]
8. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not". Volkow P; Zinser JW; Correa-Rotter R BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117 [TBL] [Abstract][Full Text] [Related]
9. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612 [TBL] [Abstract][Full Text] [Related]
10. Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin. Castiñeiras I; Almagro M; Rodríguez-Lozano J; Fernández-Jorge B; Paradela S; Pozo JD; Fonseca E J Dermatolog Treat; 2006; 17(6):377-80. PubMed ID: 17853313 [TBL] [Abstract][Full Text] [Related]
11. Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient. Gheith O; Bakr A; Wafa E; Fouda A; El Agroudy A; Refaie A; Donia A; Sabry A; Sobh M; Shokeir A; Ghoneim M Clin Exp Nephrol; 2007 Sep; 11(3):251-254. PubMed ID: 17891357 [TBL] [Abstract][Full Text] [Related]
12. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. Dezube BJ Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241 [TBL] [Abstract][Full Text] [Related]
13. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229 [TBL] [Abstract][Full Text] [Related]
14. Classic Kaposi's sarcoma associated with human herpesvirus 8 infection in a 13-year-old male: a case report. Landau HJ; Poiesz BJ; Dube S; Bogart JA; Weiner LB; Souid AK Clin Cancer Res; 2001 Aug; 7(8):2263-8. PubMed ID: 11489800 [TBL] [Abstract][Full Text] [Related]
15. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? Sodhi A; Montaner S; Gutkind JS FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988 [TBL] [Abstract][Full Text] [Related]
16. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Sodhi A; Montaner S; Patel V; Gómez-Román JJ; Li Y; Sausville EA; Sawai ET; Gutkind JS Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4821-6. PubMed ID: 15047889 [TBL] [Abstract][Full Text] [Related]
17. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug. Nichols LA; Adang LA; Kedes DH PLoS One; 2011 Jan; 6(1):e14535. PubMed ID: 21264294 [TBL] [Abstract][Full Text] [Related]
19. Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient. Ho CM; Huang SF; Hu RH; Ho MC; Wu YM; Lee PH Clin Transplant; 2010; 24(1):127-32. PubMed ID: 19919613 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome. Speicher DJ; Sehu MM; Johnson NW; Shaw DR J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]